12/6/2018
• Posted by Provider Relations
On January 1, 2019, the Medicare Preferred Drugs list will change. To ease the transition, impacted members and providers have been notified of the upcoming changes.
11/30/2018
• Posted by Provider Relations
As a Medicare/Medicare-Medicaid provider, you know that quality health care is a high priority for Fidelis Care and the Centers for Medicare & Medicaid Services (CMS). CMS considers statin use an important quality measure in patients with diabetes.
11/30/2018
• Posted by Provider Relations
Fidelis Care is pleased to inform you that the most recent 2018 QARR Non-Compliance Report has been posted on Provider Access Online (provider portal). This information is indicative of all encounter data on file with Fidelis Care as of 10/15/2018.
11/29/2018
• Posted by Provider Relations
The following sections of the Fidelis Care authorization grids have been updated effective January 1, 2019. The following services apply to all product lines of business and require prior authorization:
11/27/2018
• Posted by Provider Relations
As a Medicare/Medicare-Medicaid provider, you know that quality health care is a high priority for Fidelis Care and the Centers for Medicare & Medicaid Services (CMS). CMS and the New York State Department of Health consider DMARD use an important quality measure in patients with Rheumatoid Arthritis (RA).
Newer Articles